Eva Galante studied Chemistry as an undergraduate and postgraduate at the University of Catania, Italy. As a postgraduate she won a 2004 research fellowship at the Consiglio Nazionale delle Ricerche (CNR), during which she investigated natural products chemistry.
In 2010, she acquired her PhD in Chemical Science from the University of Catania, where she had worked on the development of anti-tumour vaccine candidates based on tumour-associated glycomimetic antigens. As part of her doctoral programme, she spent a year at the John Innes Centre in Norwich researching new glycoconjugates acting as anti-parasite against Trypanosoma cruzi.
Dr Galante has served as a postdoctoral researcher at the University College of London, where she initially worked on the development of new tracers for positron emission tomography (PET) imaging of brain proteins associated with neurological disease and responsible for drug resistance, and subsequently on the development of chemotherapeutic agents against neuroblastoma.
After serving as a teaching fellow in Chemistry at Queen Mary University of London, she was appointed Lecturer in Chemistry at the University of East London.
Dr Galante's primary research interest lies in medicinal chemistry, with particular focus on natural products and investigation of new treatments for solid tumour.